These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16254620)

  • 21. Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models.
    Valdman E; Kapitsa I; Ivanova Е; Voronina TI; Ardashov O; Volcho K; Khazanov V; Salakhutdinov N
    Eur J Pharmacol; 2017 Nov; 815():351-363. PubMed ID: 28939292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model.
    Zhang Y; Chen Y; Li L; Hölscher C
    Behav Brain Res; 2015 Oct; 293():107-13. PubMed ID: 26187689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact.
    Lau YS; Novikova L; Roels C
    Neurosci Res; 2005 Aug; 52(4):371-8. PubMed ID: 15936837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.
    Ardashov OV; Pavlova AV; Il'ina IV; Morozova EA; Korchagina DV; Karpova EV; Volcho KP; Tolstikova TG; Salakhutdinov NF
    J Med Chem; 2011 Jun; 54(11):3866-74. PubMed ID: 21534547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Anandhan A; Janakiraman U; Manivasagam T
    Neuroscience; 2012 Aug; 218():257-67. PubMed ID: 22634505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
    Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
    Laloux C; Petrault M; Lecointe C; Devos D; Bordet R
    Pharmacol Res; 2012 May; 65(5):514-22. PubMed ID: 22391246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
    Fornai F; Schlüter OM; Lenzi P; Gesi M; Ruffoli R; Ferrucci M; Lazzeri G; Busceti CL; Pontarelli F; Battaglia G; Pellegrini A; Nicoletti F; Ruggieri S; Paparelli A; Südhof TC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3413-8. PubMed ID: 15716361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental parkinsonian syndrome in rats induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine].
    Kryzhanovskiĭ GN; Atadzhanov MA; Zagorevskiĭ VA; Sharkova LM; Voronina TA
    Biull Eksp Biol Med; 1988 Apr; 105(4):397-401. PubMed ID: 3258764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
    Teismann P; Ferger B
    Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
    Sarkar S; Chigurupati S; Raymick J; Mann D; Bowyer JF; Schmitt T; Beger RD; Hanig JP; Schmued LC; Paule MG
    Neurotoxicology; 2014 Sep; 44():250-62. PubMed ID: 25064079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low doses of apomorphine transiently reduce locomotor activity in MPTP-treated mice.
    Gunzler SA; Shakil S; Carlson NE; Nutt JG; Meshul CK
    Neurosci Lett; 2007 Nov; 428(2-3):64-7. PubMed ID: 17964074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.
    Zhang W; Shin EJ; Wang T; Lee PH; Pang H; Wie MB; Kim WK; Kim SJ; Huang WH; Wang Y; Zhang W; Hong JS; Kim HC
    FASEB J; 2006 Dec; 20(14):2496-511. PubMed ID: 17142799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.